Clinical Trials Directory

Trials / Completed

CompletedNCT01988415

New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction for Myopia

A Prospective Study to Evaluate the Feasibility of a New Treatment Algorithm for Wavefront-Guided Lasik Correction of Myopic Refractive Errors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Abbott Medical Optics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this clinical trial is to demonstrate that treatments generated by an investigational algorithm reduces spherical aberration compared to currently available iDesign treatments.

Detailed description

Post-LASIK induction of spherical aberration is currently among the most prominent challenges for refractive surgery. The presence of significant spherical aberration in the visual system results in reduced contrast sensitivity, visual symptoms such as "glare" and "halos," and "night myopia" or the induction of myopia under low lighting (larger pupil size). A modified Treatment Planning Software (TPS) "VSS-Rx1 OPM software" has been developed that uses a modified algorithm (software that designs the LASIK treatment profile) to limit the induction of postoperative spherical aberration. Commercially available software used to calculate the LASIK treatment profile was used in one eye (active comparator \[i.e., control\]) and VSS-Rx1 OPM software was used in the fellow eye (experimental). Subjects were masked to the use of either the commercially available or VSS-Rx1 OPM software.

Conditions

Interventions

TypeNameDescription
DEVICEVSS-Rx1 OPM vs Commercial iDesign TreatmentCommercially available iDesign treatment planning software used to calculate the LASIK treatment profile vs VSS-Rx1 OPM (includes a modified algorithm designed to reduce the induction of postoperative spherical aberration).

Timeline

Start date
2013-11-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2013-11-20
Last updated
2016-02-05
Results posted
2016-02-05

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT01988415. Inclusion in this directory is not an endorsement.